{"podcast":{"title":"Dr. Chapa’s OBGYN Clinical Pearls","slug":"dr-chapa-s-obgyn-clinical-pearls-334380","podcast_index_feed_id":334380,"rss_url":"https://anchor.fm/s/2e36780/podcast/rss","website_url":"https://podcasters.spotify.com/pod/show/dr-hector-chapa","image_url":"https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/384576/384576-1768440224971-ee9f5571e6f7f.jpg","author":"Dr. Chapa’s Clinical Pearls","episode_count":1149,"summary":"Relevant, evidence based, and practical information for medical students, residents, and practicing healthcare providers regarding all things women’s healthcare! This podcast is intended to be clinically relevant, engaging, and FUN, because medical education should NOT be boring! Welcome...to Clinical Pearls.","last_synced_at":"2026-06-07T18:17:15.975297+00:00","page_url":"https://stenobird.com/podcast/dr-chapa-s-obgyn-clinical-pearls-334380"},"episode":{"title":"CGMs in GDM: Evolving Support","slug":"cgms-in-gdm-evolving-support","published_at":"2026-04-06T11:00:00+00:00","page_url":"https://stenobird.com/podcast/dr-chapa-s-obgyn-clinical-pearls-334380/cgms-in-gdm-evolving-support","show_page_url":"https://stenobird.com/podcast/dr-chapa-s-obgyn-clinical-pearls-334380","url":"https://podcasters.spotify.com/pod/show/dr-hector-chapa/episodes/CGMs-in-GDM-Evolving-Support-e3hfppg","audio_url":"https://traffic.megaphone.fm/APO6532799103.mp3","summary":"Modern medicine has come a long way in its fight against diabetes. We now have continuous glucose monitors (CGM) and automated insulin delivery (AIDs) systems. These have revolutionized patient care. The FDA has approved devices for use in pregnancy as “nonadjunctive use” (meaning they may be used alone), although capillary finger stick assessments are currently still considered the Gold Standard. While the most robust data in support of CGMs is for preexisting Type 1 DM (Class B or beyond) and Type 2, there is recent growing support for CGM use in GDM patients, although some limitations still apply. Listen in for details. 1. Feig DS, et al; CONCEPTT Collaborative Group. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial. Lancet. 2017 Nov 25;390(10110):2347-2359. doi: 10.1016/S0140-6736(17)32400-5. Epub 2017 Sep 15. Erratum in: Lancet. 2017 Nov 25;390(10110):2346. 2. Benhalima K, Durnwald C, Sweeting A et al.Application of continuous glucose monitoring and automated insulin delivery technologies for pregnant women with type 1, type 2, or gestational diabetes: an international consensus statement The Lancet Diabetes & Endocrinology, 2025; 14, 157-177 3. Salmen BM, Reurean-Pintilei D, Salmen T, Bohîlțea RE. Exploring Continuous Glucose Monitoring in Gestational Diabetes: A Systematic Review. Life (Basel). 2025 Aug 28;15(9):1369. doi: 10.3390/life15091369. PMID: 41010309; PMCID: PMC12470761. 4. Wyckoff JA, Lapolla A, Asias-Dinh BD, et al.Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline. The Journal of Clinical Endocrinology and Metabolism. 2025 5. American Diabetes Association Professional Practice Commit…","meta_description":"Modern medicine has come a long way in its fight against diabetes. We now have continuous glucose monitors (CGM) and automated insulin delivery (AIDs) sys…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1444,"processing_state":"processed","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/dr-chapa-s-obgyn-clinical-pearls-334380/episodes/cgms-in-gdm-evolving-support/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/dr-chapa-s-obgyn-clinical-pearls-334380/cgms-in-gdm-evolving-support.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}